Shares of Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report) hit a new 52-week low during trading on Monday . The company traded as low as GBX 12 ($0.15) and last traded at GBX 12.68 ($0.16), with a volume of 8805 shares changing hands. The stock had previously closed at GBX 12.66 ($0.16).
Celadon Pharmaceuticals Trading Up 0.2 %
The stock’s fifty day moving average price is GBX 26.49 and its 200 day moving average price is GBX 49.49. The stock has a market cap of £8.73 million, a P/E ratio of -156.25 and a beta of -0.26. The company has a current ratio of 1.92, a quick ratio of 6.97 and a debt-to-equity ratio of 194.82.
About Celadon Pharmaceuticals
Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products used to treat chronic pain, as well as autism spectrum disorders. Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom.
Further Reading
- Five stocks we like better than Celadon Pharmaceuticals
- 3 Fintech Stocks With Good 2021 Prospects
- How to Master Trading Discipline: Overcome Emotional Challenges
- The 3 Best Blue-Chip Stocks to Buy Now
- Trump Tax Reforms: 7 Stocks That Could Benefit in 2025
- Quiet Period Expirations Explained
- 3 Stocks Near 52-Week Lows: Why They Could Be Smart Buys Today
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
